OTC drug interactions "not a significant public health problem" -- Degge report.
This article was originally published in The Tan Sheet
Executive Summary
OTC DRUG INTERACTIONS "NOT SIGNIFICANT PUBLIC HEALTH PROBLEM," DEGGE REPORT concludes. Contracted by the Non-prescription Drug Manufacturers Association, the Nov. 1 report by the Degge Group, Ltd. reviews epidemiological data on OTC drug interactions against the backdrop of OTC use patterns in the U.S. The report was included in NDMA's Nov. 14 proposal to FDA on OTC label reform.